Evidence map›Paper›PMID 35650131›Full record

ArticleInternal medicine (Tokyo, Japan)2023

Clinical Usefulness of the "MN Criteria" - the Clostridioides difficile Infection Severity Scoring System - in the Japanese Setting.

Minami Asaoka, Yasuhiro Horita, Chiharu Wachino, Shuhei Kondo, Yuji Hotta, Tomoya Kataoka, Akimasa Sanagawa, Tomoaki Hayakawa, Atsushi Nakamura, Kazunori Kimura

Open access · diamondAbstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Medicina (Kaunas, Lithuania) · 2025
    Article
  2. Article
  3. Gastroenterological Surgery and Management ofJournal of the anus, rectum and colon · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Minami AsaokaDepartment of Clinical Pharmaceutics, Graduate School of Medical Sciences, Nagoya City University, Japan.
Yasuhiro HoritaDepartment of Clinical Pharmaceutics, Graduate School of Medical Sciences, Nagoya City University, Japan.
Chiharu WachinoDepartment of Clinical Pharmaceutics, Graduate School of Medical Sciences, Nagoya City University, Japan.
Shuhei KondoDivision of Infection Prevention and Control, Nagoya City University Hospital, Japan.
Yuji HottaDepartment of Pharmacy, Nagoya City University Hospital, Japan.
Tomoya KataokaDepartment of Clinical Pharmaceutics, Graduate School of Medical Sciences, Nagoya City University, Japan.
Akimasa SanagawaDepartment of Pharmacy, Nagoya City University Hospital, Japan.
Tomoaki HayakawaDepartment of Pharmacy, Nagoya City University Hospital, Japan.
Atsushi NakamuraDivision of Infection Prevention and Control, Nagoya City University Hospital, Japan.
Kazunori KimuraDepartment of Clinical Pharmaceutics, Graduate School of Medical Sciences, Nagoya City University, Japan.
Nagoya City University Hospital · JPNagoya City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective The severity of Clostridioides difficile infection (CDI) is an important prognostic factor. The "MN criteria," proposed in Japan in 2017, attempted to remedy the shortfalls in the reported guidelines proposed globally to determine CDI severity. We therefore assessed the accuracy of the MN criteria and validated the important factors associated with predicting CDI severity. Methods Sixty-six CDI cases were investigated retrospectively at a Japanese University Hospital from January 2015 to December 2018. The fulminant cases were screened out, and the non-fulminant cases were classified according to their severity stages using the nine variables included in the MN criteria. Clinical events, such as death within 28 days, colectomy, and admission to the intensive care unit, were evaluated. First, the sensitivity and specificity of the MN criteria for predicting clinical events were determined. The relationships between clinical events and the explanatory variables were then evaluated through univariate and multivariate analyses. Results The screening of the fulminant cases and classification of the non-fulminant cases into mild/moderate and severe/super severe cases resulted in a sensitivity of 1.00 and a specificity of 0.89. Univariate and multivariate analyses revealed a significant association of the serum albumin (Alb) level as well as white blood cell (WBC) count with clinical events. Conclusion The findings provide evidence supporting the accuracy of the MN criteria in predicting CDI severity and show that the Alb and WBC are important variables in predicting CDI severity.

Indexed as

Clostridioides difficileClostridium InfectionsHumansJapanPrognosisRetrospective StudiesRisk FactorsClostridioides difficileClostridioides difficile infectionMN criteriaseverity scoring system

Identifiers

PMID35650131
PMCPMC9876729
OpenAlexW4282934551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.